
RPG Life Sciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-05-21 08:01:30RPG Life Sciences Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a modest day gain of 0.29%, the company’s technical indicators present a complex picture, with bullish signals on weekly MACD and Bollinger Bands contrasting with mildly bearish monthly trends and daily moving averages. This nuanced technical landscape warrants close attention from investors navigating the Pharmaceuticals & Biotechnology sector.
Read More
RPG Life Sciences Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals
2026-05-12 08:03:11RPG Life Sciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock exhibits a complex interplay of technical indicators that suggest cautious investor sentiment amid volatile price action.
Read MoreRPG Life Sciences Gains 1.45%: Mixed Technical Signals and Rating Upgrade Shape the Week
2026-05-09 17:10:54Key Events This Week 4 May: Week opens at Rs.2,423.80 5 May: Sharp 4.26% decline amid mixed technical signals 6 May: Upgrade to Hold rating by MarketsMOJO; technical momentum shifts 7 May: Strong rebound with 3.98% gain 8 May: Week closes at Rs.2,458.95, up 1.45% for the week Week Open Rs.2,423.80 ...
Read More
RPG Life Sciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-05-06 08:02:07RPG Life Sciences Ltd has witnessed a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, despite a day’s decline of 4.26% to close at ₹2,320.50. This transition is underscored by a complex interplay of technical indicators, reflecting both optimism and caution among investors in the Pharmaceuticals & Biotechnology sector.
Read More
RPG Life Sciences Ltd Sees Mixed Technical Signals Amid Price Momentum Shift
2026-05-05 08:02:41RPG Life Sciences Ltd has experienced a notable shift in price momentum, reflected in a 5.50% gain on 5 May 2026, closing at ₹2,423.80. Despite this surge, technical indicators present a nuanced picture, with mixed signals across weekly and monthly timeframes, prompting a reassessment of the stock’s outlook within the Pharmaceuticals & Biotechnology sector.
Read MoreAre RPG Life Sciences Ltd latest results good or bad?
2026-04-30 19:16:24RPG Life Sciences Ltd's latest financial results for Q4 FY26 present a mixed picture. The company reported a net profit of ₹29.90 crores, reflecting a sequential recovery with a notable increase of 35.11% compared to the previous quarter. However, this figure represents a decline of 14.40% year-on-year, indicating challenges in sustaining profitability over a longer period. In terms of net sales, RPG Life Sciences recorded ₹176.89 crores, which is a slight decrease of 1.74% from the prior quarter but shows a modest year-on-year growth of 2.42%. This tepid revenue growth raises concerns about the company's ability to expand its market share effectively within the competitive pharmaceutical sector. The operating margin, excluding other income, was reported at 18.56%, which marks a significant contraction of 350 basis points from the previous quarter and a more substantial decline from the same quarter last ...
Read More
RPG Life Sciences Ltd Surges 12.5% to Day's High of Rs 2232 — Outperforms Sector by 10.8 Percentage Points
2026-04-30 09:45:57The Sensex declined by 1.05% on 30 Apr 2026, while RPG Life Sciences Ltd surged 12.51%, outperforming its Pharmaceuticals & Biotechnology sector by nearly 11 percentage points. This sharp single-session gain stands out as a clear stock-specific event amid a broadly weak market environment.
Read More
RPG Life Sciences Ltd is Rated Sell
2026-04-28 10:10:03RPG Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read MoreClarification sought from RPG Life Sciences Ltd
12-Jun-2026 | Source : BSEThe Exchange has sought clarification from RPG Life Sciences Ltd on June 12 2026 with reference to Movement in Volume.
The reply is awaited.
Clarification For Volume Movement Letter
12-Jun-2026 | Source : BSEClarification for Volume Movement Letter
Communication To Shareholders - Intimation On Dividend Taxation Provisions
09-Jun-2026 | Source : BSECommunication to shareholders - Intimation on dividend Taxation provisions
Corporate Actions
No Upcoming Board Meetings
RPG Life Sciences Ltd has declared 250% dividend, ex-date: 27 Jun 25
No Splits history available
No Bonus history available
No Rights history available